Cultivation of HepG2.2.15 on Cytodex-3: higher yield of hepatitis B virus and less subviral particles compared to conventional culture methods.
OBJECTIVE
Several novel systems are available to study human hepatitis B virus (HBV) replication in cell culture demanding for efficient cell culture based systems for HBV production. The aim was to enhance HBV production of the HBV stably producing cell line HepG2.2.15 by cultivation on spherical micro substrate.


METHODS
HepG2.2.15 was cultivated on microcarrier substrate Cytodex-3. HBV specific transcripts, viral protein and genome secretion, cell proliferation and MAP kinase signaling were analyzed. Infectivity of HBV particles was analyzed using primary tupaia hepatocytes.


RESULTS
Compared to stationary flask cultures, HepG2.2.15 on Cytodex-3 secreted 18-fold more HBV genomes, more HBeAg per culture volume and less HBV surface antigen per extracellular viral genome equivalent. This was reflected by a significantly higher infectivity of supernatant derived from carrier grown HepG.2.2.15 cells tested by infection of primary tupaia hepatocytes. The amount of phosphorylated ERK-2 was significantly elevated in cells cultivated on microcarrier.


CONCLUSIONS
The cultivation of HepG2.2.15 on Cytodex-3 increased production of infectious HBV particles and decreased secretion of subviral particles compared to the stationary cell cultivation. Microcarrier cultivation activates MAP kinase signaling that is crucial for HBV replication.
Lupberger
Joachim
J
Robert Koch Institute, Molecular Virology NG1, Berlin, Germany.
Mund
Andreas
A
Kock
Josef
J
Hildt
Eberhard
E
D006528:Carcinoma, Hepatocellular; D002452:Cell Count; D018929:Cell Culture Techniques / Q000379:methods*; D045744:Cell Line, Tumor; D003470:Culture Media; D003911:Dextrans; D006509:Hepatitis B / Q000821:virology*; D006514:Hepatitis B Surface Antigens / Q000378:metabolism; D006513:Hepatitis B e Antigens / Q000378:metabolism; D006515:Hepatitis B virus / Q000254:growth & development* / Q000472:pathogenicity; D006801:Humans; D008113:Liver Neoplasms; D020935:MAP Kinase Signaling System; D008863:Microspheres; D019950:Mitogen-Activated Protein Kinase 1 / Q000378:metabolism; D014771:Virion / Q000254:growth & development* / Q000472:pathogenicity; D014774:Virulence
D003470:Culture Media; D003911:Dextrans; D006514:Hepatitis B Surface Antigens; D006513:Hepatitis B e Antigens; C052839:Cytodex; D019950:Mitogen-Activated Protein Kinase 1